ArticleLeukemia2023

Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression).

Gabriel Scheubeck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.